Kei Muro

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.

Naotoshi Sugimoto, Yasuhiro Shimada, David Ferry, 2014, The Lancet. Oncology.

Comprehensive Registry of Esophageal Cancer in Japan, 2002

Soji Ozawa, Hodaka Numasaki, Teruki Teshima, 2010, Esophagus.

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy

Yasuo Hamamoto, K. Muro, Y. Hamamoto, 2011, Cancer Chemotherapy and Pharmacology.

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.

Gary Middleton, Takayuki Yoshino, Chloe E Atreya, 2018, Cancer discovery.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.

K. Muro, Kei Muro, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer

Masahiro Yoshida, Shinji Tanaka, Tetsuya Hamaguchi, 2011, International Journal of Clinical Oncology.